Thrombosis and Anticoagulation Strategies in Patients with COVID-19 Including Japanese Perspective

Coronavirus disease 2019 (COVID-19) has become a major health problem worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory infectious disease, it could also cause cardiovascular complications, including thrombosis. Thus, anticoagulation therapy has been thought to hel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Yugo, Kobayashi, Takao, Mo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067339/
https://www.ncbi.nlm.nih.gov/pubmed/36792179
http://dx.doi.org/10.5551/jat.RV22002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067339/
https://www.ncbi.nlm.nih.gov/pubmed/36792179
http://dx.doi.org/10.5551/jat.RV22002

Ejemplares similares